SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex ($CETX) is trending due to high volatility and speculation around a potential short squeeze, fueled by a massive surge in volume and borrow rates. The community is actively debating entry points, potential price targets, and whether the stock can replicate the moves of other recent high-flying, low-float stocks. Some traders cite the company's small market cap and high revenue as reasons for optimism.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid a potential bidding war for Warner Bros. Discovery, with Paramount making a competing offer and raising questions about regulatory hurdles. The community is debating the merits of the deal, potential impacts on Netflix's financials, and the influence of political factors on the outcome. Investors are weighing whether Netflix should pursue the acquisition or focus on organic growth.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

AlphaTime Acquisition Corp ($ATMC) is trending due to significant after-hours volatility, with community members citing its status as a recently merged SPAC with a low float as a potential catalyst for a large price swing. Some traders are pointing to similarities with other low-float runners and anticipating a substantial move, while others are expressing skepticism and cautioning against potential risks associated with the stock's rapid price increase.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending due to increasing interest in its low float and potential for a short squeeze, with traders drawing comparisons to other recent high-flying stocks like TWG and XCUR; some are attributing momentum to news around nuclear and SMR (small modular reactor) technology, and potential ties to Amazon data center initiatives, fueling speculation for a significant price surge.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending due to a significant surge following positive Phase 1 data for its obesity drug, WVE-007; however, some investors are wary of a potential offering. The community is actively debating the stock's future, with some anticipating further gains while others predict a pullback. Discussions also involve the drug's potential to disrupt the weight-loss market and competition with GLP-1 therapies.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending following positive Phase 2 data for its drug burixafor in multiple myeloma patients, with discussions focusing on the small float and potential for a significant price surge. Despite some concerns about the company's cash position and potential dilution, the stock is seeing increased momentum and mentions of a possible short squeeze. Community members are also weighing in on potential outcomes with recent news.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid reports of Paramount launching a hostile all-cash takeover bid at $30 per share, challenging Netflix's existing offer and sparking debate about the best path forward. Community discussions revolve around the potential for a bidding war and the deal's implications for the streaming landscape, with some seeing Paramount's offer as a superior deal for shareholders.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending due to speculation around potential acquisition following positive clinical trial data for its oral GLP-1 candidate, aleniglipron; community discussions revolve around its efficacy and safety profile compared to competitors, particularly in light of recent developments in the obesity drug market and concerns about liver toxicity. Some traders are noting the potential for a secondary offering soon. There are also buyout rumors, with some saying NVO may make a bid.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

ALT is trending as investors eagerly await the 48-week data readout and EoP2 FDA meeting news expected this month, which could serve as a major catalyst for the stock. Community discussions revolve around the potential for breakthrough therapy designation and the drug's competitive positioning in the MASH treatment landscape. Some traders are also comparing ALT to other tickers with recent surges, speculating on similar potential.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

AlphaVest Acquisition Corp ($ATMV) is trending due to discussions around a potential merger and its low float, leading to speculation of a significant short squeeze. The stock's volatility and comparisons to previous high runners like $ATMC and $SMX are fueling community excitement. Some traders are noting pre-market surges and overnight gains, while others caution about potential halts and the risks associated with low-float stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


thanhluanpg88

Nguyễn Thành Luân